NCT07287527 · RECRUITING
Effects of Photobiomodularion on Brain Connectivity and Cognitive Function in Cognitive Impairment
This trial is testing whether shining near-infrared light on the brain — a technique called transcranial photobiomodulation — can improve memory and how brain regions talk to each other in people with amnestic mild cognitive impairment. Participants also do cognitive training, and researchers use brain scans to track changes. Phase NA here means it is a controlled feasibility or pilot study — not yet at the stage of a large proven treatment.
You may qualify if
- Age 55 years or older
- Diagnosis of amnestic Mild Cognitive Impairment (aMCI)
You're excluded if
- Presence of a neurological disorder
- Presence of a severe psychiatric disorder
- Having a pacemaker or other implanted medical device that is not MRI-compatible
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-12-17